Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Jul 2006):

Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.

Full Abstract

The purpose of the present paper was to study the effect of continuation electroconvulsive therapy (ECT) on the prevention of relapse in middle-aged and elderly patients with intractable catatonic schizophrenia. It was found that continuation ECT is efficacious to sustain remission for patients who suffer relapse after response to acute ECT despite continuation neuroleptics. However, three patients suffered relapse during continuation ECT, therefore the effect of adjusting the frequency of continuation ECT and maintenance ECT was investigated in these patients with catatonic schizophrenia who relapsed during continuation ECT. These patients with DSM-IV catatonic schizophrenia who relapsed during continuation ECT were treated with more frequent continuation ECT and subsequent maintenance ECT after response to acute ECT. The patients' Brief Psychiatric Rating Scale (BPRS) scores were prospectively evaluated until relapse. Patients were considered to be relapsers if they had a BPRS score >or=37 for 3 consecutive days. The three patients with catatonic schizophrenia who relapsed during continuation ECT were treated successfully with more frequent continuation ECT and subsequent maintenance ECT. No patient experienced a severe adverse effect from continuation or maintenance ECT. More frequent continuation ECT and maintenance ECT deserves consideration in middle-aged and elderly patients with intractable catatonic schizophrenia who suffer relapse during continuation ECT. Large-scale systematic studies are warranted to investigate the optimum use of continuation and maintenance ECT in patients with catatonic schizophrenia.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Suzuki, Kazumasa (K); Awata, Shuichi (S); Takano, Takehisa (T); Ebina, Yukio (Y); Shindo, Tsuyoshi (T); Harada, Nobuhiko (N); Matsuoka, Hiroo (H);

Affiliation: Department of Psychiatry, Tohoku University Hospital, Sendai, Japan. kazumasa-tohoku(-atsign-)umin.ac.jp

Journal and publication information

Publication Type: Journal Article

Journal: Psychiatry and clinical neurosciences (Psychiatry Clin Neurosci), published in Australia. (Language: eng)

Reference: 2006-Aug; vol 60 (issue 4) : pp 486-92

Dates: Created 2006/08/03; Completed 2006/09/20;

PMID: 16884452, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antipsychotic Agents (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

4/29/1976
11/29/2007
Higher Relevance Score (16)
Lower Relevance Score (10)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index